Related Experiment Videos
Is group-specific meningococcal vaccination resulting in epidemics caused by groups of virulent meningococci?
Abstract:
In 1976 routine vaccination against Neisseria meningitidis serogroups A and C was started in the Finnish Armed Forces. A case of fulminant, complicated pneumonia caused by group-Y meningococcus in a vaccinated recruit, prompted a study of the distribution of the meningococcal groups isolated from the recruits in the same unit. 14 (46%) of the 31 isolates from 84 recruits were group Y. Group-Y meningococcus was rarely isolated from unvaccinated controls. These results suggest that widespread vaccination against serogroups A and C may have led to an increase in the frequency of meningococcus group Y.
Insights
Routine vaccination against Neisseria meningitidis serogroups A and C in the Finnish military coincided with a rise in group Y infections. This suggests that A and C vaccinations may have inadvertently increased the prevalence of meningococcus group Y.
Area of Science:
- Microbiology
- Epidemiology
- Vaccinology
Background:
- Routine vaccination against Neisseria meningitidis serogroups A and C was implemented in the Finnish Armed Forces in 1976.
- A severe case of pneumonia caused by group Y meningococcus occurred in a vaccinated recruit.
Observation:
- A study investigated meningococcal group distribution among recruits in the same unit.
- 14 out of 31 isolates (46%) from 84 recruits were identified as group Y.
- Group Y meningococcus was infrequently found in unvaccinated control individuals.
Findings:
- The widespread vaccination against serogroups A and C appears correlated with an increased frequency of Neisseria meningitidis group Y.
- This observation suggests a potential serogroup replacement phenomenon following mass vaccination efforts.
Implications:
- The findings highlight the importance of monitoring meningococcal group epidemiology post-vaccination.
- Further research is needed to understand the mechanisms behind this potential serogroup shift and its impact on public health.
- Consideration of broader-spectrum meningococcal vaccines may be warranted to address emerging serogroup prevalence.